While some evidence is suggestive of novel roles for AR and PSMA as tumor-suppressor activity in androgen-independent prostate cancer cells (2,32), the loss of AR and PSMA expression may be a consequence of dedifferentiation or a stem cell-like transition of prostate cancer cells (33) induced by androgen deprivation. The gene discussed is FOLH1; the disease is prostate carcinoma.